Holen Sie sich die Stockscreener-App
1.03
0.97%
0.00
Finanzdaten der Phio Pharmaceuticals Corp-Aktie (PHIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | 0.231 |
Operating Expenses
|
1.16%
2.534
|
2.505 | 2.309 | 1.872 | 1.674 |
| Operating Income/Loss |
1.16%
-2.534
|
-2.505 | -2.309 | -1.872 | -1.674 |
| Income/Loss From Continuing Operations Before Tax |
0.88%
-2.371
|
-2.392 | -2.166 | -1.769 | 5.755 |
| Income/Loss From Continuing Operations After Tax |
0.88%
-2.371
|
-2.392 | -2.166 | -1.769 | -1.626 |
|
Net Income/Loss
|
0.88%
-2.371
|
-2.392 | -2.166 | -1.769 | -1.626 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
79.43%
1.1249
|
5.4686 | 4.7949 | 4.3073 | 0.1166 |
| Basic Earnings Per Share |
65.91%
-0.15
|
-0.44 | -0.45 | -0.41 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):